Search results (22)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
OCION 2024 Funding Scheme is live!
7 June 2024
The 2024 Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is now open!
£9m to Oxford for the Next Generation of Cancer Experts
4 April 2024
Cancer Research UK awards funding to the CRUK Oxford Centre to support future cancer research leaders.
Children’s Cancer and Leukaemia Group Funding for Anindita Roy
20 July 2023
New research, led by Professor Anindita Roy, is to be funded by families affected by childhood cancer through Children’s Cancer and Leukaemia Group (CCLG)'s Special Named Fund programme.
Nuffield Department of Medicine receives funding to improve bowel cancer treatment
23 November 2022
The Leedham Lab in the Nuffield Department of Medicine (NDM) has been awarded over £2M from Cancer Research UK to develop a new tool that could help guide how bowel cancer patients are treated in the future.
Funding boost for Oxford’s cancer research in the NIHR Oxford BRC
14 October 2022
The NIHR Oxford Biomedical Research Centre (BRC), a partnership between the University of Oxford and Oxford University Hospitals (OUH) NHS Foundation Trust, will receive £86.6m over the next five years to fund 15 research themes.
Funding to research metformin’s ability to delay or prevent cancers driven by the mutated TP53 gene
29 September 2022
A research project embedded within the Metformin in Li Fraumeni (MILI) trial will investigate metformin’s mechanism of action when taken as a preventative for mTP53-driven cancers.
CRUK funding to investigate the molecular drivers of stomach cancer
8 September 2022
Dr Francesco Boccellato wins a CRUK Early Detection and Diagnosis primer award to study tissue shape changes in the pre-cancerous stomach conditions, atrophic gastritis and intestinal metaplasia
Cancer Research UK to invest £11 million into cancer science in Oxford
24 January 2022
A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.
14 new CRUK Oxford Centre Development Fund Awardees
1 July 2021
The awardees from the 2021 round of the CRUK Oxford Centre Development fund have been announced. Read about what research they will be undertaking.
Oxford wins government funding to evaluate prostate cancer detection system
24 June 2021
A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University.
Oxford success at the early detection sandpit on pancreatic cancer
22 April 2021
Professor Eric O’Neill and Dr Pui San Tan receive funding as part of teams applying novel approaches for the early detection of pancreatic cancer.
Further funding secured to hunt out cancer using innovative radiotherapy techniques
20 April 2021
Initial success leads to new award for Oxford researcher pushing forward new cancer-hunting radiotherapy.
Early Detection Award for research into the clinical application of single cell genomics
7 April 2021
Dr Onima Chowdhury will investigate the clinical application of single cell sequencing for early diagnosis and response prediction in myelodysplastic syndromes.
New funding for early diagnosis research using platelets
30 March 2021
Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.
Funding to improve childhood, teenage and young adult cancer detection
26 March 2021
Dr Defne Saatci and Professor Julia Hippisley-Cox will develop risk prediction tools using the QResearch database to support the earlier detection of childhood, teenage and young adult cancer
Prof Andi Roy receives new award for immune-cell research
18 March 2021
Co-funded by Cancer Research UK and Children with Cancer UK, Andi is one of 5 to receive £1 million each to investigate children’s and young people’s cancers.
Studying viral genetics to aid liver cancer early detection
15 February 2021
Professor Ellie Barnes and Dr Azim Ansari receive funding to identify cancer-associated strains of hepatitis C in Pakistan to improve assessment of liver cancer risk.
Christina Ye awarded CRUK pre-doctoral fellowship
11 February 2021
Christina Ye has been awarded CRUK pre-doctoral fellowship, she tells us about her upcoming project into T cell trafficking between the blood and skin when patients undergo checkpoint immunotherapy
New Oxford spin-out Singula Bio launches
3 February 2021
Singula Bio, co-founded by Professors Ahmed Ahmed, Enzo Cerundolo and Enda McVeigh from the Nuffield Department of Women’s & Reproductive Health, aims to become a world leader in developing neoantigen-based individualised cell therapies to use against difficult-to-treat solid malignancies such as ovarian cancer.
Oxford spin out financed $6.8m for research into oncolytic therapies
7 January 2021
Oxford spin out company Theolytics has closed a $6.8m deal to support their work into developing novel cancer therapies from viruses